NLRP3 and periodontitis: Previous studies have shown that expression levels of NF-κB and NLRP3 are significantly elevated in the periodontitis animal models, while chemical inhibitors of NF-κB and NLRP3 or their downregulation can significantly reduce the periodontitis-induced alveolar bone loss [40–43].